Rosetta Inpharmatics

oligo-based inkjet DNA microarray gene expression, bioinformatics solutions, gene expression profiling

History:

Rosetta Inpharmatics is now a wholly owned subsidiary of Merck & Co.. The microarry printing technology has been sold off to Agilent, and Rosetta Biosoftware (maker of the Resolver Gene Expression Data Analysis System) was formed as a business unit.

Employment

Email:

Fax:

Mail:

General Info:

Ticker: subsidiary

Employees:

Regions:
Pacific Northwest

Research Focus:

 

Profiles: BioMedNet

 

News:

Keywords: 

Strategic Partnerships: